The present invention relates to a stent graft designed to treat Type-A dissections, that is dissections occurring close to the heart in the ascending aorta. The present invention also relates to an introducer assembly for the deployment of a stent graft into the ascending aorta to treat Type-A dissections. The stent graft and introducer assembly disclosed herein can also be used to treat aortic ruptures, transactions, coronary dissections, valve ruptures, cardiac tamponades, distal malperfusions and other similar defects.
This application claims priority to Great Britain Patent Application No. GB0920327.4, filed Nov. 19, 2009, and is further related to U.S. Provisional Application Ser. No. 61/262,839, filed Nov. 19, 2009, U.S. patent application Ser. No. 12/622,351, filed Nov. 19, 2009, now U.S. Pat. No. 8,740,966, issued Jun. 3, 2014, and is further related to co-pending U.S. application Ser. No. 12/946,233, filed Nov. 15, 2010, co-pending U.S. application Ser. No. 12/945,097, filed Nov. 10, 2010, and Great Britain Patent Application No. GB0920235.9, filed Nov. 18, 2009, all of which are incorporated by reference in their entirety.
Dissections occur when the wall of a lumen tears, creating a secondary or false lumen. Blood can flow into this false lumen, generally causing the vessel to balloon outwardly as a result of the weaker lumen wall. If the dissection is left untreated, there is the risk of rupture of the lumen, with severe consequences to the patient. Dissections can be treated by open surgery, involving closing the tear by suturing and/or strengthening of the lumen wall, again often by suturing. Open surgery procedures should, however, preferably avoided, particularly to the thoracic region, in light of the trauma caused to the patient. For this purpose, some endoluminal treatments have been developed in which the dissection is treated by means of a stent or stent graft placed against the damaged portion of the vessel wall. The stent or stent graft acts to press together the two parts of the lumen wall so as to close off the false lumen. It have been found that if the false lumen can be closed, the lumen wall often repairs itself. A stent graft can usefully be placed at the point of the tear, so as to close off the blood supply to the false lumen. This removes the blood pressure in the false lumen and thus allows the two parts of the lumen wall to come into contact one another and thus to heal in time.
The use of stents and stent grafts to treat dissections has been restricted to lumen locations and zones which are free of complications, such as branch vessels, complex lumen geometries and so on, particularly in light of the difficulties in placing the stent and stent grafts accurately in the lumen. As a result of the particular complexities of Type-A dissections, that is dissections in the ascending aorta, stents or stent grafts have not been used. At this location, there is only a short length of aorta which is free of side branches critical to the health of the patient. The geometry of the lumen, that is beyond the aortic arch, also causes positioning difficulties.
More particularly, a Type-A thoracic aorta dissection (TAD-A) is a condition in which the intimal layer of the ascending thoracic aorta develops a tear, allowing blood to flow into the layers of the aortic wall, causing the development of medial or subintimal hematoma. TAD-A is associated with a very high mortality rate of around 1 to 2% per hour for the first 48 hours. Currently, the only option for treatment of TAD-As is open surgical repair which includes opening the chest cavity, clamping the aorta and sewing a vascular prosthesis in place. Operative mortality rate for TAD-A is significant at approximately 10%.
The ability to treat a TAD-A quickly is imperative but current procedures are lengthy, invasive and associated with high morbidity and mortality. The ability to treat TAD-As through endovascular procedures would represent a significant step forward and reduction in mortality rates. However, the ascending aortic arch is complex by reason of the coronary arteries and brachiocephalic artery and that any obstruction of these can lead to patient demise. As a result of this, the treatment of Type-A dissections and other vascular defects in the ascending aorta still remains restricted to open surgical procedures.
The present invention seeks to provide a stent graft assembly for the treatment of Type-A dissections and to an introducer assembly able to place a stent graft in the ascending aorta for the treatment of Type-A dissections. The stent graft and introducer assembly disclosed herein can also be used to treat aortic ruptures, transactions, coronary dissections, valve ruptures, cardiac tamponades, distal malperfusions and other similar defects.
According to an aspect of the present invention, there is provided a stent graft for treatment of defects in the ascending aorta including a tubular portion of graft material provided with proximal and distal ends, a plurality of stent rings attached to the graft tube, at least one bare stent extending from the proximal end of the graft tube and designed to flare outwardly relative to the graft tube so as to engage in use the aortic sinus of a patient.
This arrangement of stent graft has the advantage of maintaining the stent graft in position and preventing its migration. This can be particularly useful given the disadvantages of using barbs in this part of a patient's anatomy, and such that the preferred embodiment of stent graft is provided with no barbs at all and at least no barbs in its proximal end. Therefore, this structure can provide a medical device able to treat vascular defects in the ascending aorta.
In practice, the bare stent is designed and arranged to be located in the bulbous part of the aorta by the aortic arteries and by the heart itself. This bare stent can thus assist in holding the stent graft in position in the lumen.
In the preferred embodiment, there are provided bare stents at both the proximal and distal ends of the graft tube. The bare stent at the distal end of the graft tube can assist in the anchoring of the stent graft in the ascending aorta, to prevent migration of this over the brachiocephalic artery. The distal bare stent preferably flares outwardly relative to the graft tubing
The or each bare stent is preferably formed of an undulating stent structure, to provide a series of fingers arranged circumferentially around the graft tubing and having curved ends or apices. This design of bare stent avoids sharp points to the stent structure and therefore minimizes trauma to the vessel walls.
In the preferred embodiment, the graft tubing is in the region of 65 mm in length and the or each bare stent extends from the graft tubing by around 10 mm.
According to another aspect of the present invention, there is provided a method of treating a vascular defect in the ascending aorta of a patient including the steps of locating in the ascending aorta a stent graft provided with a tubular portion of graft material provided with proximal and distal ends, a plurality of stent rings attached to the graft tube, at least one bare stent extending from the proximal end of the graft tube and designed to flare outwardly relative to the graft tube, said positioning locating the bare stent in the aortic sinus of a patient so as to anchor the stent graft in position.
According to another aspect of the present invention, there is provided a stent graft including a tubular portion of graft material provided with proximal and distal ends, a plurality of stent rings attached to the graft tube, and at least first and second diameter restraining devices, the first diameter restraining device being located at or proximate the proximal end of the graft tube, the or at least one second diameter restraining device being located in an intermediate position along the graft tube.
The diameter restraining devices provide for the graft tube and thus the stent graft to be deployed at an initial, partially expanded state in which the graft tube can expand radially outwardly in those zones thereof not restrained by the restraining devices, with the central portion of the graft tube being kept in a constrained configuration. The keeps the stent graft in a configuration in which it can be repositioned within the patient's lumen prior to full deployment thereof. Once the stent graft is in the correct and precise position, the restraining devices can be released to deploy the stent graft fully in the lumen.
Such repositioning is extremely important in being able to treat Type-A dissections by means of stent grafts, in that the position of the stent graft can be adjusted very precisely, ensuring that the graft tube does not block either the coronary arteries or the brachiocephalic artery.
In the preferred embodiment, the restraining devices are diameter reducing loops disposed circumferentially around the graft tube. Such loops can be used in combination with trigger wires to restraining the diameter of the stent graft at the location of the loops.
Preferably, there are provided at least two intermediate diameter restraining devices, operable to restrain proximal and distal ends of a stent located on the graft tube or a plurality of stents positioned in an intermediate position along the graft tube.
The diameter restraining devices can thus allow the proximal and distal zones of the graft tubing to expand outwardly in a first deployment stage, generally on withdrawal of the outer sheath of the introducer assembly. This provides a first deployed condition of the stent graft in which portions of the stent graft may contact the lumen walls yet still be movable.
In the preferred embodiment, the stent graft includes at least one bare stent extending from a proximal end of the graft tube. Such a bare stent can have the function of maintaining the stent graft in position and preventing its migration. This can be particularly useful given the disadvantages of using barbs in this part of a patient's anatomy.
Advantageously, the bare stent is designed to flare outwardly relative to the graft tubing. In practice, the bare stent is designed and arranged to be located in the bulbous part of the aorta by the aortic arteries and by the heart itself. This bare stent can thus assist in holding the stent graft in position in the lumen.
In the preferred embodiment, there are provided bare stents at both the proximal and distal ends of the graft tube. The bare stent at the distal end of the graft tube can assist in the anchoring of the stent graft in the ascending aorta, to prevent migration of this over the brachiocephalic artery. The distal bare stent preferably flares outwardly relative to the graft tubing
The or each bare stent is preferably formed of an undulating stent structure, to provide a series of fingers arranged circumferentially around the graft tubing and having curved ends or apices. This design of bare stent avoids sharp points to the stent structure and therefore minimizes trauma to the vessel walls.
Advantageously the graft tubing is in the region of 65 mm in length and the or each bare stent extends from the graft tubing by around 10 mm.
In the preferred embodiment, the stent graft is provided with a stent section extending from the distal end of the graft tubing. In use, the stent section extends across the brachiocephalic, left common cartoid and left subclavian arteries. Being of open construction, the stent does not impinge upon the flow of blood into these arteries while providing support to the graft section against its migration. The stent section could be integral with the graft section, that is of unitary construction, but in the preferred embodiment is formed as a separate component deployable after deployment of the stent graft section.
According to another aspect of the present invention, there is provided an introducer assembly for deploying a stent graft as specified herein, the introducer assembly including a carrier for carrying the stent graft, an outer sheath movable from a position covering the carrier to a withdrawn position exposing the carrier; the introducer assembly including a plurality of restraining elements for maintaining the restraining devices of the stent graft in a radially compressed configuration after withdrawal of the sheath.
The restraining elements are thus able to keep the stent graft attached to an partially deployed on the introducer for final positioning before complete deployment.
Advantageously the restraining elements include one or more trigger wires. In one embodiment, the trigger wires are arranged to restrain the proximal bare stent as well as the restraining devices and to release these from a proximal most position to a distal most position upon withdrawal of the restraining wires. The restraining wires may also hold the distal end of the stent graft, for instance the distal bare stent where this is provided. The restraining wires can thus allow for staged deployment from the proximal-most part of the stent graft to its distal end.
In another embodiment, there may be provided a plurality of sets of trigger wires for releasing the stent graft in a different sequence than from one end of the graft tube to the other. For instance, one set of trigger wires may be arranged to release the distal end of the stent graft first and one or more other sets of trigger wires arranged to release other portions of the stent graft, for instance its proximal end and/or the central portion whether together or independently of one another.
Advantageously, the introducer is provided with a pliable dilator tip able to be passed through a patient's heart valve during the deployment procedure.
Embodiments of the present invention are described below, by way of example only, with reference to the accompanying drawings, in which:
Referring to
Until now dissections and aneurisms could be treated only in the descending aorta 12 by way of stents and stent grafts, in light of the difficulty of positioning such devices accurately in the aortic arch 14 or the ascending aorta 22 and as a result of the numerous arterial branches leading off these parts of the aorta. Particular difficulties arise with dissections or aneurisms occurring at the mouth of the heart and proximate or bridging the coronary arteries, as shown for instance in the dotted outlines in
In practice, the length of lumen of the ascending aorta 22 free of branch arteries is no more than around 50 to 60 mm, meaning that any medical device to be located in this area must be positioned very accurately in order not to run the risk of blocking any of the branching arteries or causing trauma to the tissue of the lumen walls.
Referring to
The stent graft 40 includes a tube 42 of graft material, which may be any of the currently available graft materials or other materials contemplated in the art. The graft tube 42 preferably has a length of around 50-70 mm, in the preferred embodiment around 65 mm, and a diameter in the range from 28 mm to 46 mm. These dimensions do, of course, depend upon the size of a patient's ascending aorta 22 and the distance between the coronary arteries 26, 28 and the brachiocephalic artery 16.
In this embodiment, the stent graft 40 is provided with five stent rings 44, 46, 48, 50 and 52, two of which, that is stents 44 and 52, are bare stents which extend beyond the extremities of the graft tube 42. The other three stent rings 46-50 are, in this embodiment, disposed on the inside of the graft tube 42 and are spaced along its length, such that the rings 46 and 50 are proximate the ends of the graft tube while the stent ring 48 is approximately at its centre.
The bare stents 44 and 52 have, in the preferred embodiment, rounded apices 54 to minimize the risk of damage to the vessel walls. Although the preferred embodiment has two bare stents, a proximal stent 44 and a distal stent 52, the distal stent 52 may be omitted. It will be seen from the drawings that at least the proximal bare stent 44 flares outwardly, that is radially beyond the graft tube 42. The distal bare stent 52 may flare in similar manner.
The internal stent rings 46, 48, 50 may be conventional zigzag stent rings with pointed apices, although could have rounded apices as the bare stents 44 and 52, or any other suitable stent ring design.
In the embodiment shown, the stent rings 44, 46, 48, 50, 52 are sutured to the graft tube in conventional manner although they could be secured to the graft tube 42 by any other suitable means.
Fitted to the graft tube 42 are a plurality of diameter restraining devices, in this embodiment diameter reducing suture loops 56, 58, 60. The proximal suture loop 56 extends around the proximal end of the graft tube 42 and in this embodiment feeds into and out of the graft material to provide a plurality of portions of thread substantially evenly radially spaced on the inside of the graft tube, for tying to the carrier of an introducer, as described in further detail below. The diameter reducing loop 56 is usefully threaded into the inside of the graft tube at the apices of the stent 44, such that the stent structure provides support for the loop 56.
The intermediate diameter reducing loops 58, 60 are, in this embodiment, provided at either end of the middle stent ring 48 and again feed into the inside of the graft tube 42 at the apices of the stent ring 48.
In this embodiment, the distal end of the stent graft 40 is not provided with any diameter reducing loops. In other embodiments, a further diameter reducing loop may be provided at this end of the graft tube 42.
It will be appreciated that there could be provided a single intermediate diameter reducing loop 58, 60 or more than two, in dependence upon the design of the stent ring 48 and the number of stent rings provided in the central portion of the graft tube 42. It is preferred in this embodiment to have two intermediate diameter reducing loops 58, 60 in order to constrain the central stent ring 48 at both of its ends to a carrier of the introducer, as shown in further detail below.
Referring now to
Referring now to
Referring now to
Referring now to
The proximal bare stent 44 locates into the bulbous region 23 of the aorta just by the heart opening 24 and across the coronary arteries 26, 28. Given its flaring configuration, the bare stent opens out into the bulbous region 23 and acts to assist in holding the stent graft 40 in position. The graft section 42 extends over the entry point or tear 80 forming the opening of the dissection, and down close to the brachiocephalic artery 16.
The distal stent 70 is positioned such that its proximal end fits inside and against the stent graft 40 and extends across the branch arteries 16, 18, 20. The stent 70 acts to press the distal end of the stent graft 40 against the lumen walls and to maintain the position of the stent graft 40, thereby to prevent its migration.
In some embodiments the stent graft 40 and stent 70 could be formed integrally, that is as a unitary structure. It is preferred, however, that the two are separate components.
Although
The stent graft 40 also preferably includes the distal bare stent 52, which has the function of anchoring the stent graft 40 against upstream migration, thereby preventing migration to the aortic valves. The bare stents 44, 52 thus enable the stent graft not to have any barbs, which can cause damage to the vessel walls.
The amount of bare stent which is exposed beyond the graft tube 42 can be controlled by the position of the sutures holding the bare stent.
Although the embodiment of stent graft shown has the stents 46, 48 and 50 located inside the graft tube 42, in the preferred embodiment, the middle stent 48 is located on the outside of the graft tube 42. In this manner, the stent 48 acts as a body stent providing longitudinal and circumferential stability to the device ensuring that the device confirms to the vasculature and does not buckle when deployed in angulated and/or tortuous anatomies. The stent 46 and 50 are sealing stents which ensure good sealing of the stent graft 40 to the vessel walls.
This embodiment of stent graft may also be used with a distal stent of the type shown in
The graft tube, as with the embodiment of
In all embodiments, the stents are preferably formed from shape memory material, preferably Nitinol.
Referring now to
The proximal attachment region 116 of the introducer 110 includes a dilator tip 120, which is typically provided with a bore 122 therein for receiving a guide wire (not shown) of conventional type. The longitudinal bore 122 also provides a channel for the introduction of medical reagents. For example, it may be desirable to supply a contrast agent to allow angiography to be performed during placement and deployment phases of the medical procedure.
A guide wire catheter 124, conventionally made from a flexible thin walled metal tube, is fastened to the dilator tip 120. The guide wire catheter 124 is flexible so that the introducer 100 can be advanced along a relatively tortuous vessel, such as a femoral artery, and so that the distal attachment region 114 can be longitudinally and rotationally manipulated. The guide wire catheter 124 extends through the introducer 100 to the manipulation section 112, terminating at a connection device 126, in conventional manner.
The connection device 126 is designed to accept a syringe to facilitate the introduction of reagents into the inner catheter 124. The guide wire catheter 124 is in fluid communication with apertures 128 in the flexible dilator tip 120. Therefore, reagents introduced into connection device 126 will flow to and emanate from the apertures 128.
A pusher sheath or rod 130 (hereinafter referred to as a pusher member), typically made from a plastics material, is mounted coaxial with and radially outside of the guide wire catheter 124. The pusher member 130 is “thick walled”, that is the thickness of its wall is preferably several times greater than that of the guide wire catheter 124.
A sheath 132 extends coaxially over and radially outside of the pusher member 130. The pusher member 130 and the sheath 132 extend distally to the manipulation region 112.
The implant 118, which in this embodiment is the stent graft 40, is retained in a compressed condition by the sheath 132. The sheath 132 extends distally to a sheath manipulator and haemostatic sealing unit 134 of the external manipulation section 112. The haemostatic sealing unit 134 includes a haemostatic seal (not shown) and a side tube 136 held to the unit 134 by a conventional luer lock 138.
The sheath manipulator and haemostatic sealing unit 134 also includes a clamping collar (not shown) that clamps the sheath 132 to the haemostatic seal and a silicone seal ring (not shown) that forms a haemostatic seal around the pusher rod 130. The side tube 138 facilitates the introduction of medical fluids between the pusher rod 130 and the sheath 132. Saline solution is typically used.
During assembly of the introducer 100, the sheath 132 is advanced over the proximal end of the dilator tip 120 of the proximal attachment region 116 while the implant 118 is held in a compressed state by an external force. A suitable distal attachment (retention) section (not visible in this view) is coupled to the pusher rod 130 and retains a distal end 140 of the prosthesis 118 during the procedure.
The distal end of the prosthesis 118 is provided with a plurality of trigger wires 142, 144. A proximal portion of the external manipulation section 112 includes at least one release wire actuation section 150 mounted on a body 148, in turn mounted onto the pusher member 130. The guide wire catheter 124 passes through the body 148. The trigger wire release mechanisms 146, 150 are mounted for slidable movement on the body 148.
A haemostatic seal (not shown) is included so that the release wires can extend out through the body 148 without unnecessary blood loss during the medical procedure.
A proximal portion of the external manipulation section 112 includes a pin vise 154 mounted onto the proximal end of the body 148. The pin vise 154 has a screw cap 156. When screwed in, vise jaws (not shown) of the pin vise 154 clamp against or engage the guide wire catheter 124. When the vise jaws are engaged, the guide wire catheter 124 can only move with the body 148 and hence it can only move with the pusher member 130. With the screw cap 156 tightened, the entire assembly can be moved together as one piece. Once the introducer assembly 112 is in the desired deployment position, the sheath 132 is withdrawn to just proximal of the distal attachment section 114.
Referring now to
In the preferred embodiment, there are provided three trigger wires 142, 144, which are arranged to be operated together. The trigger wires 142, 144 pass through the bore in the carrier 130 and by apertures at positions representative of the ends of the bare stents 44, 52 as well as at the diameter reducing suture loops 56, 58, 60. In this manner, the trigger wires can tie down, that is constrain radially, the stent graft 40 into the configuration shown in
The outer sheath 132 covers the stent graft for the deployment procedure, thus pressing the entirety of the stent graft 40 against the carrier 124.
On deployment, once the distal end of the introducer 100 has been fed endoluminally to the treatment site, that is to the ascending aorta 22, the sheath 132 is pulled back, that is withdrawn, to expose the stent graft 40. Once released from the sheath, the stent graft 40 is able to deploy to its partly expanded position, shown in
In many instances, the stent graft 40 will abut against the false lumen walls and thus be partially held in place by these, until full deployment thereof.
The trigger wires are withdrawn further, releasing in sequence, the diameter reducing loops 58 and 60 and then the distal bare stent 52. Thus, the stent graft 40 is deployed in stages and in a manner that its position can be precisely adjusted.
Once the stent graft 40 has been deployed, the distal stent 70 is deployed in a second phase of the deployment operation, by expanding this such that its proximal end fits within the distal end of the stent graft 40, as shown for instance in
As explained above, in other embodiments, the deployment sequence can be altered, particularly by providing additional trigger mechanisms. For instance, the distal bare stent 52 could be retained by a sleeve rather than the trigger wires, and thus deployable independently of the trigger wires. In another embodiment, there may be provided a plurality of sets of trigger wires, for instance two sets, each coupled to respective ones of the bare stents and diameter reducing loops, so as to be able to effect deployment of the bare stents and body of the graft tube in a sequence preferred by the surgeon or suited for a particular deployment procedure. For instance, in some circumstances it might be desired to deploy the body of the stent graft 40 before releasing the end of the stent graft, that is the bare stents 44, 52. In another example, it might be desired to deploy the stent graft 40 from its distal end first.
Number | Date | Country | Kind |
---|---|---|---|
0920327.4 | Nov 2009 | GB | national |
Number | Name | Date | Kind |
---|---|---|---|
5258021 | Duran | Nov 1993 | A |
5292331 | Boneau | Mar 1994 | A |
5403341 | Solar | Apr 1995 | A |
5569295 | Lam | Oct 1996 | A |
5607468 | Rogers et al. | Mar 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5674278 | Boneau | Oct 1997 | A |
5749921 | Lenker et al. | May 1998 | A |
5782904 | White et al. | Jul 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5906639 | Rudnick et al. | May 1999 | A |
5913897 | Corso, Jr. et al. | Jun 1999 | A |
5961546 | Robinson et al. | Oct 1999 | A |
5993482 | Chuter | Nov 1999 | A |
6071307 | Rhee et al. | Jun 2000 | A |
6110198 | Fogarty et al. | Aug 2000 | A |
6203569 | Wijay | Mar 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6287315 | Wijeratne et al. | Sep 2001 | B1 |
6293966 | Frantzen | Sep 2001 | B1 |
6296662 | Caffey | Oct 2001 | B1 |
6336937 | Vonesh et al. | Jan 2002 | B1 |
6346118 | Baker et al. | Feb 2002 | B1 |
6348068 | Campbell et al. | Feb 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6368345 | Dehdashtian et al. | Apr 2002 | B1 |
6423090 | Hancock | Jul 2002 | B1 |
6451051 | Drasler et al. | Sep 2002 | B2 |
6471722 | Inoue | Oct 2002 | B1 |
6514282 | Inoue | Feb 2003 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6539984 | Lam | Apr 2003 | B2 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6582458 | White et al. | Jun 2003 | B1 |
6585757 | Callol | Jul 2003 | B1 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6616689 | Ainsworth et al. | Sep 2003 | B1 |
6629994 | Gomez et al. | Oct 2003 | B2 |
6635083 | Cheng et al. | Oct 2003 | B1 |
6645242 | Quinn | Nov 2003 | B1 |
6648911 | Sirhan et al. | Nov 2003 | B1 |
6663661 | Boneau | Dec 2003 | B2 |
6673102 | Vonesh et al. | Jan 2004 | B1 |
6695875 | Stelter et al. | Feb 2004 | B2 |
6723116 | Taheri | Apr 2004 | B2 |
6740115 | Lombardi et al. | May 2004 | B2 |
6849088 | Dehdashtian et al. | Feb 2005 | B2 |
6860901 | Baker et al. | Mar 2005 | B1 |
6878160 | Gilligan et al. | Apr 2005 | B2 |
6962604 | Hijlkema | Nov 2005 | B2 |
6974471 | Van Schie et al. | Dec 2005 | B2 |
7147657 | Chiang et al. | Dec 2006 | B2 |
7186263 | Golds et al. | Mar 2007 | B2 |
7232459 | Greenberg et al. | Jun 2007 | B2 |
7264632 | Wright et al. | Sep 2007 | B2 |
7279003 | Berra et al. | Oct 2007 | B2 |
7318835 | Berra | Jan 2008 | B2 |
7331992 | Randall et al. | Feb 2008 | B2 |
7341598 | Davidson et al. | Mar 2008 | B2 |
7407509 | Greenberg et al. | Aug 2008 | B2 |
7473275 | Marquez | Jan 2009 | B2 |
7534258 | Gomez et al. | May 2009 | B2 |
7615072 | Rust et al. | Nov 2009 | B2 |
7722657 | Hartley | May 2010 | B2 |
7758626 | Kim et al. | Jul 2010 | B2 |
7766962 | Quinn | Aug 2010 | B1 |
7794492 | Ishimaru et al. | Sep 2010 | B2 |
7828837 | Khoury | Nov 2010 | B2 |
7887580 | Randall et al. | Feb 2011 | B2 |
7927363 | Perouse | Apr 2011 | B2 |
8043354 | Greenberg et al. | Oct 2011 | B2 |
8128678 | Leewood et al. | Mar 2012 | B2 |
8206427 | Ryan et al. | Jun 2012 | B1 |
8292943 | Berra et al. | Oct 2012 | B2 |
8333799 | Bales et al. | Dec 2012 | B2 |
8348994 | Leopold et al. | Jan 2013 | B2 |
8394136 | Hartley et al. | Mar 2013 | B2 |
8425586 | Leopold et al. | Apr 2013 | B2 |
8480725 | Rasmussen et al. | Jul 2013 | B2 |
8574284 | Roeder et al. | Nov 2013 | B2 |
8728145 | Chuter et al. | May 2014 | B2 |
8740966 | Brocker et al. | Jun 2014 | B2 |
8992593 | Chuter et al. | Mar 2015 | B2 |
9180030 | Brocker et al. | Nov 2015 | B2 |
9220617 | Berra | Dec 2015 | B2 |
9226813 | Brocker et al. | Jan 2016 | B2 |
9226814 | Jensen et al. | Jan 2016 | B2 |
9345595 | Brocker et al. | May 2016 | B2 |
20010000188 | Lenker et al. | Apr 2001 | A1 |
20020016627 | Golds | Feb 2002 | A1 |
20020022877 | Mueller et al. | Feb 2002 | A1 |
20020032487 | Dua et al. | Mar 2002 | A1 |
20020143381 | Gilligan et al. | Oct 2002 | A1 |
20020177890 | Lenker | Nov 2002 | A1 |
20030033002 | Dehdashtian et al. | Feb 2003 | A1 |
20030033003 | Harrison et al. | Feb 2003 | A1 |
20030050684 | Abrams et al. | Mar 2003 | A1 |
20030088305 | Van Schie et al. | May 2003 | A1 |
20030120263 | Ouriel et al. | Jun 2003 | A1 |
20030120331 | Chobotov et al. | Jun 2003 | A1 |
20030125797 | Chobotov et al. | Jul 2003 | A1 |
20030130720 | DePalma et al. | Jul 2003 | A1 |
20030199967 | Hartley et al. | Oct 2003 | A1 |
20040002751 | Gilligan et al. | Jan 2004 | A1 |
20040054396 | Hartley et al. | Mar 2004 | A1 |
20040073289 | Hartley | Apr 2004 | A1 |
20040093063 | Wright et al. | May 2004 | A1 |
20040106978 | Greenberg et al. | Jun 2004 | A1 |
20040117003 | Ouriel et al. | Jun 2004 | A1 |
20040117004 | Osborne et al. | Jun 2004 | A1 |
20040176833 | Pavcnik et al. | Sep 2004 | A1 |
20040215316 | Smalling | Oct 2004 | A1 |
20040215319 | Berra et al. | Oct 2004 | A1 |
20040254625 | Stephens et al. | Dec 2004 | A1 |
20050033406 | Barnhart et al. | Feb 2005 | A1 |
20050049674 | Berra et al. | Mar 2005 | A1 |
20050075730 | Myers et al. | Apr 2005 | A1 |
20050090834 | Chiang | Apr 2005 | A1 |
20050102022 | Solovay et al. | May 2005 | A1 |
20050113905 | Greenberg et al. | May 2005 | A1 |
20050119722 | Styrc et al. | Jun 2005 | A1 |
20050131516 | Greenhalgh | Jun 2005 | A1 |
20050154446 | Phillips et al. | Jul 2005 | A1 |
20050159803 | Lad et al. | Jul 2005 | A1 |
20050222669 | Purdy | Oct 2005 | A1 |
20050222671 | Schaeffer et al. | Oct 2005 | A1 |
20050240257 | Ishimaru et al. | Oct 2005 | A1 |
20050240258 | Bolduc et al. | Oct 2005 | A1 |
20050273155 | Bahler et al. | Dec 2005 | A1 |
20060004433 | Greenberg et al. | Jan 2006 | A1 |
20060004436 | Amarant et al. | Jan 2006 | A1 |
20060052860 | Gomez et al. | Mar 2006 | A1 |
20060100695 | Peacock, III et al. | May 2006 | A1 |
20060161243 | Fearnot et al. | Jul 2006 | A1 |
20060184228 | Khoury | Aug 2006 | A1 |
20060190070 | Dieck et al. | Aug 2006 | A1 |
20060190075 | Jordan et al. | Aug 2006 | A1 |
20060247761 | Greenberg et al. | Nov 2006 | A1 |
20060265054 | Greenhalgh et al. | Nov 2006 | A1 |
20060267247 | Anukhin et al. | Nov 2006 | A1 |
20070027525 | Ben-Muvhar | Feb 2007 | A1 |
20070043425 | Hartley et al. | Feb 2007 | A1 |
20070055345 | Arbefeuille | Mar 2007 | A1 |
20070055347 | Arbefeuille | Mar 2007 | A1 |
20070067016 | Jung | Mar 2007 | A1 |
20070073388 | Krolik et al. | Mar 2007 | A1 |
20070100427 | Perouse | May 2007 | A1 |
20070135889 | Moore et al. | Jun 2007 | A1 |
20070142894 | Moore et al. | Jun 2007 | A1 |
20070150051 | Arnault De La Menardiere et al. | Jun 2007 | A1 |
20070162103 | Case et al. | Jul 2007 | A1 |
20070163668 | Arbefeuille et al. | Jul 2007 | A1 |
20070168019 | Amplatz et al. | Jul 2007 | A1 |
20070179592 | Schaeffer | Aug 2007 | A1 |
20070185560 | Roeder et al. | Aug 2007 | A1 |
20070191927 | Bowe et al. | Aug 2007 | A1 |
20070203566 | Arbefeuille et al. | Aug 2007 | A1 |
20070208256 | Marilla | Sep 2007 | A1 |
20070219620 | Eells et al. | Sep 2007 | A1 |
20070219624 | Brown et al. | Sep 2007 | A1 |
20070225797 | Krivoruhko | Sep 2007 | A1 |
20070233220 | Greenan | Oct 2007 | A1 |
20070233223 | Styrc et al. | Oct 2007 | A1 |
20070244547 | Greenan | Oct 2007 | A1 |
20070250152 | Xiao et al. | Oct 2007 | A1 |
20070282433 | Limon et al. | Dec 2007 | A1 |
20080033527 | Nunez et al. | Feb 2008 | A1 |
20080039920 | Peacock et al. | Feb 2008 | A1 |
20080086190 | Ta | Apr 2008 | A1 |
20080109066 | Quinn | May 2008 | A1 |
20080114441 | Rust et al. | May 2008 | A1 |
20080114445 | Melsheimer et al. | May 2008 | A1 |
20080119943 | Armstrong et al. | May 2008 | A1 |
20080140178 | Rasmussen et al. | Jun 2008 | A1 |
20080195191 | Luo et al. | Aug 2008 | A1 |
20080269866 | Hamer et al. | Oct 2008 | A1 |
20080281399 | Hartley et al. | Nov 2008 | A1 |
20080319534 | Birdsall et al. | Dec 2008 | A1 |
20090005856 | Pappas et al. | Jan 2009 | A1 |
20090043376 | Hamer et al. | Feb 2009 | A1 |
20090048663 | Greenberg | Feb 2009 | A1 |
20090105809 | Lee et al. | Apr 2009 | A1 |
20090138072 | Gendreau | May 2009 | A1 |
20090149946 | Dixon | Jun 2009 | A1 |
20090171437 | Brocker et al. | Jul 2009 | A1 |
20090177270 | Agnew et al. | Jul 2009 | A1 |
20090306763 | Roeder et al. | Dec 2009 | A1 |
20100268318 | Glynn | Oct 2010 | A1 |
20100331960 | Clerc | Dec 2010 | A1 |
20120029624 | Dierking et al. | Feb 2012 | A1 |
20120239136 | Bruzzi | Sep 2012 | A1 |
20120323307 | Richter | Dec 2012 | A1 |
Number | Date | Country |
---|---|---|
0686379 | Dec 1995 | EP |
0960607 | Dec 1999 | EP |
1372530 | Feb 2006 | EP |
1372534 | Nov 2006 | EP |
1839624 | Mar 2007 | EP |
1545396 | Dec 2008 | EP |
2005-512675 | May 2005 | JP |
2005-521471 | Jul 2005 | JP |
2009-525139 | Jul 2009 | JP |
772472 | Jun 2007 | KR |
WO 9721403 | Jun 1997 | WO |
WO 02076340 | Oct 2002 | WO |
WO 02078569 | Oct 2002 | WO |
WO 03034948 | May 2003 | WO |
WO 03053288 | Jul 2003 | WO |
WO 03082153 | Oct 2003 | WO |
WO 2004017867 | Mar 2004 | WO |
WO 2004017868 | Mar 2004 | WO |
WO 2005034810 | Apr 2005 | WO |
WO 2005099628 | Oct 2005 | WO |
WO 2006028925 | Mar 2006 | WO |
WO 2007092276 | Aug 2007 | WO |
WO 2007095283 | Aug 2007 | WO |
WO 2007098937 | Sep 2007 | WO |
WO 2008021556 | Feb 2008 | WO |
WO 2008051543 | May 2008 | WO |
2008066923 | Jun 2008 | WO |
WO 2009020653 | Feb 2009 | WO |
WO 2010024879 | Mar 2010 | WO |
2010062355 | Jun 2010 | WO |
Entry |
---|
PCT/US2010/056673 Search Report, MED Institute, Inc, May 6, 2011. |
PCT/US2010/056673 Written Opinion, MED Institute, Inc, May 6, 2011. |
Office Action received for U.S. Appl. No. 12/609,553, dated Dec. 20, 2010 (10 pages). |
Office Action received for U.S. Appl. No. 12/609,553, dated Apr. 4, 2011 (11 pages). |
Advisory Action received for U.S. Appl. No. 12/609,553, dated Jun. 3, 2011 (3 pages). |
Office Action received for U.S. Appl. No. 12/609,553, dated Oct. 11, 2011 (15 pages). |
Office Action received for related U.S. Appl. No. 12/945,097, dated Feb. 29, 2012 (14 pages). |
Office Action received for U.S. Appl. No. 12/609,553, dated Mar. 9, 2012 (16 pages). |
Advisory Action received for U.S. Appl. No. 12/609,553, dated May 24, 2012 (5 pages). |
Office Action received for related U.S. Appl. No. 12/946,233, dated Aug. 16, 2012 (18 pages). |
Notice of Panel Decision received for U.S. Appl. No. 12/609,553, dated Dec. 26, 2012 (2 pages). |
Office Action received for related U.S. Appl. No. 12/945,097, dated Dec. 26, 2012 (11 pages). |
Patent Examination Report No. 1 for corresponding Patent App. No. AU 2010322201, dated Jun. 25, 2013, (4 pages). |
Patent Examination Report No. 2 for corresponding Patent App. No. AU 2010322201, dated Aug. 7, 2013, (6 pages). |
Communication for corresponding Patent App. No. EP 20779432.3, dated May 4, 2012, (4 pages). |
Search Report under Section 17 for corresponding Patent App. No. GB 0920327.4, dated Feb. 9, 2011, (1 page). |
Translation of Office Action of corresponding Patent App. No. JP 2012-539958, dated Jun. 3, 2014, (2 pages). |
International Search Report for corresponding Patent App. No. PCT/US2010/056673, dated May 11, 2011, (16 pages). |
International Preliminary Report on Patentability for corresponding Patent App. No. PCT/US2010/056673, dated May 22, 2012, (9 pages). |
Amendment and Reply to Office Action filed in related U.S. Appl. No. 12/946,233, dated Jan. 16, 2013 (9 pages). |
Final Office Action mailed in related U.S. Appl. No. 12/946,233, dated May 7, 2013 (23 pages). |
Amendment Accompanying an RCE filed in related U.S. Appl. No. 12/946,233, dated Sep. 9, 2013 (9 pages). |
Office Action mailed in related U.S. Appl. No. 12/946,233, dated Apr. 25, 2014 (13 pages). |
Response to Non-Final Office Action filed in related application U.S. Appl. No. 12/946,233, dated Jul. 25, 2014 (8 pages). |
Office Action mailed in related application U.S. Appl. No. 12/946,233, dated Aug. 29, 2014 (13 pages). |
Response to Non-Final and Interview Summary filed in related application U.S. Appl. No. 12/946,233, dated Jan. 23, 2015 (8 pages). |
Final Office Action received for related U.S. Appl. No. 12/946,233, dated Feb. 24, 2015 (13 pages). |
After Final Pilot Response to Office Action filed in related U.S. Appl. No. 12/946,233, dated May 26, 2015 (9 pages). |
Amendment and Reply filed in related U.S. Appl. No. 12/945,097, dated Aug. 28, 2012 (8 pages). |
Final Office Action mailed in related application U.S. Appl. No. 12/945,097, dated Dec. 26, 2012 (11 pages). |
Amendment Accompanying an RCE filed in related U.S. Appl. No. 12/945,097, dated Apr. 26, 2013 (8 pages). |
Supplement Amendment filed in related U.S. Appl. No. 12/945,097, dated Jul. 24, 2013 (7 pages). |
Corrected Supplement Amendment filed in related U.S. Appl. No. 12/945,097, dated Sep. 18, 2014 (6 pages). |
Office Action received for related U.S. Appl. No. 12/945,097, dated Oct. 6, 2014 (17 pages). |
Response to Non-Final Office Action filed in related U.S. Appl. No. 12/945,097, dated Jan. 30, 2015 (14 pages). |
Amendment and Response filed in related U.S. Appl. No. 12/609,553, dated Mar. 9, 2011 (8 pages). |
Amendment and Response filed in related U.S. Appl. No. 12/609,553, dated May 25, 2011 (8 pages). |
Amendment and Response filed in related U.S. Appl. No. 12/609,553, dated Jan. 11, 2012 (15 pages). |
Final Office Action received for U.S. Appl. No. 12/609,553, dated May 9, 2012 (5 pages). |
Pre-Appeal Brief Request for Review filed for related U.S. Appl. No. 12/609,553, dated Sep. 7, 2012 (6 pages). |
Notice of Allowance received for related U.S. Appl. No. 12/609,553, dated Mar. 13, 2013 (10 pages). |
PCT Partial International Search Report for PCT/US2010/056673, date of mailed Mar. 2, 2011 (3 pages). |
First Examination Report for Australian Patent Application No. 2008341104 issued Oct. 16, 2012, 3 pages. |
Second Examination Report for Australian Patent Application No. 2008341104 issued Jul. 9, 2013, 3 pages. |
Examination Report No. 1 for AU 2014200561 dated Apr. 27, 2015, 4 pages. |
Extended European Search Report for EP12275202 dated Apr. 9, 2013, 8 pages. |
Examination Report for European Patent Application Serial No. 08 864 911.6 dated Aug. 8, 2012, 4 pages. |
Examination Report for European Patent Application Serial No. 08 864 911.6 dated Jan. 9, 2013, 4 pages. |
Examination Report for European Patent Application Serial No. 08 864 911.6 dated Nov. 10, 2014, 3 pages. |
European Search Report for European Patent Application 11174880, dated Jul. 23, 2012, 6 pages. |
Partial Search Report for European Patent Application Serial No. 11 174 880.2 dated Aug. 8, 2012, 5 pages. |
Extended Search Report for European Patent Application Serial No. 11 174 880.2 dated Feb. 8, 2013, 9 pages. |
Examination Report for European Patent Application Serial No. 11 174 880.2 dated Sep. 2, 2014, 4 pages. |
Combined Search and Examination Report for Great Britain Patent Application Serial No. 0920235.9 dated Mar. 16, 2010, 3 pages. |
Examination Report for Great Britain Patent Application Serial No. 0920235.9 dated Jun. 14, 2010, 2 pages. |
Office Action for corresponding JP 2014-203749 and translation, mailed Sep. 29, 2015, 7 pages. |
Office Action Notice of Grounds of Rejection for Japanese Patent Application No. 2010-540640 mailed Nov. 20, 2012, 8 pages including English translation. |
Office Action Notice of Grounds of Rejection for Japanese Patent Application Serial No. 2010-540640 dated Nov. 5, 2013, 7 pages, including English Translation. |
International Search Report and Written Opinion for PCT/US2008/013738 dated Feb. 19, 2009, 7 pages. |
International Preliminary Report on Patentability for PCT/US2008/013738 dated Dec. 11, 2009, 5 pages. |
International Search Report for PCT/US2011/056365 dated Jul. 18, 2012, 5 pages. |
Written Opinion for PCT/US2011/056365 dated Apr. 14, 2013, 6 pages. |
International Preliminary Report on Patentability for PCT/US2011/056365 dated Apr. 16, 2013, 7 pages. |
Non-Final Office Action for U.S. Appl. No. 12/332,904 dated Oct. 4, 2010, 8 pages. |
Final Office Action for U.S. Appl. No. 12/332,904 dated May 9, 2011, 11 pages. |
Non-Final Office Action for U.S. Appl. No. 12/332,904 dated Nov. 18, 2011, 12 pages. |
Final Office Action for U.S. Appl. No. 12/332,904 dated Jan. 3, 2013, 5 pages. |
Non-Final Office Action for U.S. Appl. No. 12/332,904 dated Jan. 14, 2015, 5 pages. |
Notice of Allowance for U.S. Appl. No. 12/332,904 dated Jul. 6, 2015, 8 pages. |
Non-Final Office Action for U.S. Appl. No. 12/472,082 dated Oct. 4, 2010, 8 pages. |
Non-Final Office Action for U.S. Appl. No. 12/472,082 dated Jun. 2, 2011, 12 pages. |
Non-Final Office Action for U.S. Appl. No. 14/472,082 dated Dec. 2, 2011, 11 pages. |
Final Office Action for U.S. Appl. No. 12/472,082 dated Sep. 13, 2012, 14 pages. |
Notice of Allowance for U.S. Appl. No. 12/472,082 dated Jun. 21, 2013, 10 pages. |
Notice of Allowance for U.S. Appl. No. 12/472,082 dated Aug. 14, 2013, 4 pages. |
Non-Final Office Action for U.S. Appl. No. 12/622,351 dated Oct. 6, 2010, 10 pages. |
Final Office Action for U.S. Appl. No. 12/622,351 dated Jun. 10, 2011, 12 pages. |
Non-Final Office Action for U.S. Appl. No. 12/622,351 dated Dec. 1, 2011, 13 pages. |
Non-Final Office Action for U.S. Appl. No. 12/622,351 dated Jun. 27, 2012, 25 pages. |
Final Office Action for U.S. Appl. No. 12/622,351 dated Apr. 3, 2013, 28 pages. |
Notice of Allowance for U.S. Appl. No. 12/622,351 dated Sep. 4, 2013, 8 pages. |
Notice of Allowance for U.S. Appl. No. 12/622,351 dated Jan. 21, 2014, 7 pages. |
Office Action Restriction Requirement for U.S. Appl. No. 12/841,807 dated Feb. 24, 2012, 9 pages. |
Non-Final Office Action for U.S. Appl. No. 12/841,807 dated Jun. 7, 2012, 9 pages. |
Final Office Action for U.S. Appl. No. 12/841,807 dated Jan. 11, 2013, 9 pages. |
Non-Final Office Action for U.S. Appl. No. 12/841,807 dated Jul. 31, 2014, 10 pages. |
Notice of Allowance for U.S. Appl. No. 12/841,807 dated Nov. 24, 2014, 7 pages. |
Non-Final Office Action for U.S. Appl. No. 12/904,452 dated May 15, 2012, 11 pages. |
Final Office Action for U.S. Appl. No. 12/904,452 dated Dec. 19, 2012, 11 pages. |
Final Office Action for U.S. Appl. No. 12/904,452 dated May 1, 2014, 11 pages. |
Advisory Action for U.S. Appl. No. 12/904,452 dated Jun. 13, 2014, 2 pages. |
Notice of Allowance for U.S. Appl. No. 12/904,452 dated Mar. 9, 2015, 5 pages. |
Notice of Allowance for U.S. Appl. No. 12/904,452 dated Aug. 27, 2015, 5 pages. |
Final Office Action for U.S. Appl. No. 12/945,097 dated Jul. 2, 2015, 10 pages. |
Advisory Action for U.S. Appl. No. 12/945,097 dated Dec. 30, 2015, 3 pages. |
Non-Final Office Action for U.S. Appl. No. 12/945,097 dated Sep. 8, 2016, 10 pages. |
Notice of Allowance for U.S. Appl. No. 12/946,233 dated Jun. 8, 2015, 11 pages. |
Non-Final Office Action for U.S. Appl. No. 13/335,142 dated Feb. 14, 2013, 16 pages. |
Notice of Allowance for U.S. Appl. No. 13/335,142 dated Sep. 23, 2013, 11 pages. |
Notice of Allowance for U.S. Appl. No. 13/335,142 dated Jan. 16, 2014, 7 pages. |
Non-Final Office Action for U.S. Appl. No. 14/293,286 dated Aug. 5, 2015, 17 pages. |
Notice of Allowance for U.S. Appl. No. 14/293,286 dated Jan. 15, 2016, 9 pages. |
Non-Final Office Action for U.S. Appl. No. 14/876,429 dated Jun. 30, 2016, 5 pages. |
Non-Final Office Action for U.S. Appl. No. 14/952,498 dated Aug. 11, 2016, 8 pages. |
Number | Date | Country | |
---|---|---|---|
20110125249 A1 | May 2011 | US |